![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
Unite de Neuropsychopharmacologie Experimentale, URA 1969 du Centre National de la Recherche Scientifique, Institut Federatif de Recherche Multidisciplinaire sur les Peptides, Faculte de Medecine et de Pharmacie de Rouen, Saint Etienne du Rouvray, F
Rats were treated once daily for 15 consecutive days with either cocaine or the specific dopamine uptake inhibitor 1-[2- (diphenylmethoxy)ethyl]-4-(3-phenyl-2-(propenyl)-piperazine (GBR12783) at a dose (10 mg/kg) that given acutely increases locomotor activity. Two or 14 days after the last administration, the motor stimulant responses of rats to a challenge dose (5 mg/kg) of the drug administered previously were compared with the motor stimulant responses of rats daily injected with solvent. A sensitization to the acute stimulant locomotor effect of these drugs was only observed 14 days after cessation of chronic treatments. After this withdrawal period, autoradiographic analysis revealed a significant decrease in the desipramine-insensitive [3H]mazindol binding to the dopamine transporter in the shell of the nucleus accumbens. No change was noticed in other regions with high dopamine content: core of nucleus accumbens, striatum, olfactory tubercle, substantia nigra and ventral tegmental area. Absence of concomitant decrease in [3H]dihydrotetrabenazine labeling, which indicates lack of effect on vesicular monoamine transporters, suggests that the decrease in accumbal [3H]mazindol binding did not result from a cytotoxic effect on corresponding dopamine neurons. In addition, 14 days after the last administration of GBR12783, the levels of dopamine and metabolites (dihydroxy-phenylacetic acid, homovanillic acid) and the ability of acute GBR12783 to synergize with haloperidol-induced increase in these metabolites were not modified either in the whole nucleus accumbens or in the striatum.
This article has been cited by other articles:
|
|
 |
|
  J. Sabeti, G. A. Gerhardt, and N. R. Zahniser Individual Differences in Cocaine-Induced Locomotor Sensitization in Low and High Cocaine Locomotor-Responding Rats Are Associated with Differential Inhibition of Dopamine Clearance in Nucleus Accumbens J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 180 - 190. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. Kimmel, F. I. Carroll, and M. J. Kuhar Withdrawal from Repeated Cocaine Alters Dopamine Transporter Protein Turnover in the Rat Striatum J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Letchworth, M. A. Nader, H. R. Smith, D. P. Friedman, and L. J. Porrino Progression of Changes in Dopamine Transporter Binding Site Density as a Result of Cocaine Self-Administration in Rhesus Monkeys J. Neurosci., April 15, 2001; 21(8): 2799 - 2807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Le Pen, D. Duterte-Boucher, and J. Costentin Sensitization to the Rewarding Effects of the Specific Dopamine Uptake Inhibitor GBR12783 J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 688 - 696. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Phillips, M. G. Huson, and C. S. McKinnon Localization of Genes Mediating Acute and Sensitized Locomotor Responses to Cocaine in BXD/Ty Recombinant Inbred Mice J. Neurosci., April 15, 1998; 18(8): 3023 - 3034. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
